Riskpilot← Back to searchSign inGet full accessHESTAVANGEN DYREKLINIKK AS
ASActiveOrg 991989080Hestavangen 19, 5700 VossVeterinary activities · NACE 7500Est. 20078 employees
Revenue 2024
NOK 17,5M
+15% vs 2023
EBITDA margin
9.6%
-35% vs 2023
Equity ratio
27.0%
Financial strength
Net profit 2024
NOK 1,3M
-39% vs 2023
| Revenue | NOK 17,5M | +15% |
| EBITDA | NOK 1,7M | -35% |
| Net profit | NOK 1,3M | -39% |
| Total assets | NOK 6,9M | -43% |
| Equity | NOK 1,9M | -77% |
| Employees | 8 | — |
Legal name
HESTAVANGEN DYREKLINIKK AS
Org number
991989080
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
11. desember 2007
Share capital
NOK 100 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Veterinærvirksomhet samt hva med dette hører til.
Address
Hestavangen 19, 5700 Voss
Phone
+4756515400
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 083 | 12 682 | 13 526 | 15 236 | 17 542 |
| Staff expenses | −6 024 | −6 002 | −6 360 | −7 450 | −9 096 |
| EBITDA | 2 160 | 2 173 | 2 356 | 2 584 | 1 678 |
| Depreciation & amort. | −77 | −79 | −69 | −33 | −84 |
| EBIT | 2 083 | 2 094 | 2 287 | 2 551 | 1 594 |
| Net financials | 42 | 47 | 51 | 220 | 196 |
| Profit before tax | 2 125 | 2 141 | 2 338 | 2 771 | 1 790 |
| Tax | 468 | 471 | 514 | 610 | 463 |
| Net profit | 1 657 | 1 670 | 1 824 | 2 161 | 1 326 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 184 | 8 950 | 9 884 | 12 003 | 6 882 |
| Equity | 4 688 | 5 258 | 5 882 | 8 043 | 1 858 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 496 | 3 692 | 4 002 | 3 960 | 5 023 |
| Total debt | 3 496 | 3 692 | 4 002 | 3 960 | 5 023 |
EBITDA margin
9.6%
This company
15.8%
Market median
-39% vs market
20202024
Equity ratio
27.0%
This company
38.2%
Market median
-29% vs market
20202024
Return on equity
71.4%
This company
18.4%
Market median
+288% vs market
20202024
Net profit margin
7.6%
This company
8.1%
Market median
-6% vs market
20202024
Asset turnover
2.55×
This company
1.12×
Market median
+128% vs market
20202024
Debt / equity
2.70×
This company
0.62×
Market median
-335% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BH Chief Executive Officer | Chief Executive Officer | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2007 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bjørn Brunborg As
HESTAVANGEN DYREKLINIKK AS Board members of HESTAVANGEN DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Helge Brunborg | Chief Executive Officer | 0 companies |
| Hilde Lunde-Brattebø | Chairman | 0 companies |